Singapore markets open in 3 hours 14 minutes

Medicus Sciences Acquisition Corp. (MSAC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
9.99+0.03 (+0.30%)
At close: 04:00PM EST

Medicus Sciences Acquisition Corp.

152 West 57th Street
20th Floor
New York, NY 10019
United States
212 259 8400

Sector(s)Financial Services
IndustryShell Companies
Full-time employees

Key executives

NameTitlePayExercisedYear born
Dr. Jacob Jay Gottlieb C.F.A., CFA, M.D.Exec. ChairmanN/AN/A1972
Dr. Michael Bernard Castor M.D.CEO & DirectorN/AN/A1971
Dr. Judah Zvi Drillick CPAChief Financial OfficerN/AN/A1977
Dr. Neil Puri M.B.A., M.D.Chief Bus. OfficerN/AN/A1981
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Medicus Sciences Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on the healthcare industry primarily the medical technology sector in the United States and internationally. The company was incorporated in 2020 and is based in New York, New York.

Corporate governance

Medicus Sciences Acquisition Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.